Charles Q. Morris
2014
In 2014, Charles Q. Morris earned a total compensation of $1.2M as Executive Vice President and Chief Development Officer at ImmunoGen, a 51% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $164,312 |
|---|---|
| Option Awards | $639,823 |
| Salary | $432,400 |
| Other | $13,199 |
| Total | $1,249,734 |
Morris received $639.8K in option awards, accounting for 51% of the total pay in 2014.
Morris also received $164.3K in non-equity incentive plan, $432.4K in salary and $13.2K in other compensation.
Rankings
In 2014, Charles Q. Morris' compensation ranked 6,581st out of 13,032 executives tracked by ExecPay. In other words, Morris earned more than 49.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,581 out of 13,032 | 50th |
Division Manufacturing | 2,399 out of 4,966 | 52nd |
Major group Chemicals And Allied Products | 809 out of 1,686 | 52nd |
Industry group Drugs | 632 out of 1,365 | 54th |
Industry Pharmaceutical Preparations | 483 out of 1,043 | 54th |
Source: SEC filing on September 29, 2015.
Morris' colleagues
We found five more compensation records of executives who worked with Charles Q. Morris at ImmunoGen in 2014.
2014
Daniel Junius
ImmunoGen
Chief Executive Officer
2014
David Johnston
ImmunoGen
Chief Financial Officer
2014
John Lambert
ImmunoGen
Executive Vice President and Distinguished Research Fellow
2014
Gregory Perry
ImmunoGen
Chief Financial Officer
2014
James O'Leary
ImmunoGen